|Articles|November 1, 2017
Almac Group Announces Acquisition of BioClin Laboratories
Advertisement
Almac Group announced the acquisition of 100% shares of BioClin Laboratories. BioClin will bring fourth its expert analytical services and analysis to increase Almac’s capacity and compliment its existing business strategic expansion which will help them to serve clients globally.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention
3
ACT Brief: AI-Driven Enrollment Results, Statistician Standards in Early Phase, and RNA Editing for Kidney Disease
4
SCOPE X: The COPD Case Study That Shows What AI Can Do for Enrollment
5